These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11063826)

  • 1. Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease?
    Sakic B; Kolb B; Whishaw IQ; Gorny G; Szechtman H; Denburg JA
    J Neuroimmunol; 2000 Nov; 111(1-2):93-101. PubMed ID: 11063826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice.
    Sakić B; Szechtman H; Denburg JA; Gorny G; Kolb B; Whishaw IQ
    J Neuroimmunol; 1998 Jul; 87(1-2):162-70. PubMed ID: 9670858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal damage in mouse and human forms of systemic autoimmune disease.
    Ballok DA; Woulfe J; Sur M; Cyr M; Sakic B
    Hippocampus; 2004; 14(5):649-61. PubMed ID: 15301441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice.
    Ballok DA; Earls AM; Krasnik C; Hoffman SA; Sakic B
    J Neuroimmunol; 2004 Jul; 152(1-2):83-97. PubMed ID: 15223241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine receptor antagonist modulates serology and affective behaviors in lupus-prone mice: evidence of autoimmune-induced pain?
    Ballok DA; Sakic B
    Brain Behav Immun; 2008 Nov; 22(8):1208-16. PubMed ID: 18601998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained Immunosuppression Alters Olfactory Function in the MRL Model of CNS Lupus.
    Kapadia M; Zhao H; Ma D; Sakic B
    J Neuroimmune Pharmacol; 2017 Sep; 12(3):555-564. PubMed ID: 28401431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course and nature of brain atrophy in the MRL mouse model of central nervous system lupus.
    Sled JG; Spring S; van Eede M; Lerch JP; Ullal S; Sakic B
    Arthritis Rheum; 2009 Jun; 60(6):1764-74. PubMed ID: 19479832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cyclophosphamide on leukocytic infiltration in the brain of MRL/lpr mice.
    Farrell M; Sakić B; Szechtman H; Denburg JA
    Lupus; 1997; 6(3):268-74. PubMed ID: 9104735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
    Chalmers SA; Wen J; Shum J; Doerner J; Herlitz L; Putterman C
    Clin Immunol; 2017 Dec; 185():100-108. PubMed ID: 27570219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive treatment prevents behavioral deficit in autoimmune MRL-lpr mice.
    Sakić B; Szechtman H; Denburg SD; Denburg JA
    Physiol Behav; 1995 Oct; 58(4):797-802. PubMed ID: 8559794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin aggravates CNS pathology in experimental systemic lupus erythematosus.
    Foxley S; Zamora M; Hack B; Alexander RR; Roman B; Quigg RJ; Alexander JJ
    Brain Res; 2013 Apr; 1504():85-96. PubMed ID: 23410788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibuprofen fails to prevent brain pathology in a model of neuropsychiatric lupus.
    Ballok DA; Ma X; Denburg JA; Arsenault L; Sakic B
    J Rheumatol; 2006 Nov; 33(11):2199-213. PubMed ID: 17086606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice.
    Anderson KK; Ballok DA; Prasad N; Szechtman H; Sakic B
    Behav Brain Res; 2006 Jan; 166(1):32-8. PubMed ID: 16183144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of functional alternative complement pathway alleviates lupus cerebritis.
    Alexander JJ; Jacob A; Vezina P; Sekine H; Gilkeson GS; Quigg RJ
    Eur J Immunol; 2007 Jun; 37(6):1691-701. PubMed ID: 17523212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining.
    Ballok DA; Millward JM; Sakic B
    Brain Res; 2003 Feb; 964(2):200-10. PubMed ID: 12576180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL13 Neutralization Attenuates Neuropsychiatric Manifestations in Lupus-Prone Mice.
    Huang MW; Stock AD; Putterman C
    Front Immunol; 2021; 12():763065. PubMed ID: 34868008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study.
    Sakić B; Denburg JA; Denburg SD; Szechtman H
    Brain Res Bull; 1996; 41(5):305-11. PubMed ID: 8924042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased TUNEL staining in brains of autoimmune Fas-deficient mice.
    Sakic B; Maric I; Koeberle PD; Millward JM; Szechtman H; Maric D; Denburg JA
    J Neuroimmunol; 2000 May; 104(2):147-54. PubMed ID: 10713354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential pathogenetic link between peripheral immune activation and the central innate immune response in neuropsychiatric systemic lupus erythematosus.
    Tomita M; Khan RL; Blehm BH; Santoro TJ
    Med Hypotheses; 2004; 62(3):325-35. PubMed ID: 14975498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis.
    Alexander JJ; Bao L; Jacob A; Kraus DM; Holers VM; Quigg RJ
    Biochim Biophys Acta; 2003 Nov; 1639(3):169-76. PubMed ID: 14636948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.